ketamine treatment for depression nasal spray - Search News

Ketamine Nasal Spray Approved

Hosted on MSN · 6h

FDA approves Johnson & Johnson’s ketamine-derived nasal spray for depression as stand-alone treatment

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult population.

Ketamine Nasal Spray Approved as Standalone Treatment for Tough Depression Cases

An emerging treatment for clinical depression has reached an important milestone. This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other options.

Fox Business · 2d

J&J's ketamine-derived nasal spray approved by FDA to treat depression

Johnson & Johnson's ketamine-derived nasal spray has been approved as a standalone treatment to fight depression for those who had an inadequate response to oral antidepressants.

J&J’s ketamine-based drug approved as standalone treatment

"Treatment-resistant depression can be very complicated, especially for patients who do not respond to oral antidepressants ...

Inquirer on MSN3d

Controlled drug Ketamine a lifeline for patients with severe depression in S’pore

Ketamine therapy is now a mainstream prescription for treatment-resistant depression. Read more at straitstimes.com.

Some results have been hidden because they may be inaccessible to you

Show inaccessible results